2021. An open-label, pilot study to evaluate the benefits of using lyophilized human milk-derived nutritional product (NeoLact 70 – 1.55 g) as an immune-nutritional supplement in premature infants discharged from NICU. Indian Journal of Child Health. 8, 12 (Dec. 2021), 404–407. DOI:https://doi.org/10.32677/ijch.v8i12.3213.